CTLA4 and melanoma: Furthermore, lack of response to anti-PD-1 or anti-CTLA-4 therapy in another melanoma cohort has been associated with baseline abundance in Ruminococcus obeum, which contradicts other preclinical/clinical data supporting that gut enrichment with Ruminococcaceae family and Ruminococcus spp.